Amantadine-induced psychosis in a young healthy patient

American Journal of Psychiatry

Volumn 165, Issue 12, 2008, Pages 1613-

  Smith, Earl Justice ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; QUETIAPINE; VENLAFAXINE;

ADULT; AUDITORY HALLUCINATION; CASE REPORT; DEPRESSION; DRUG SAFETY; DRUG WITHDRAWAL; EVENING DOSAGE; HUMAN; INFLUENZA; INFLUENZA VIRUS A; LETTER; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL; PSYCHOSIS; SLEEP DISORDER; VISUAL HALLUCINATION;

ADULT; AMANTADINE; ANTIVIRAL AGENTS; HUMANS; INFLUENZA, HUMAN; MALE; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 57349105122     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.08081228     Document Type: Letter

References (7)

1. Snoey ER, Bessen HA: Acute psychosis after amantadine overdose. Ann Emerg Med 1990; 19:668-670
2. Borison RL: Amantadine-induced psychosis in a geriatric patient with renal disease. Am J Psychiatry 1979; 136:111-112
3. Symmetrel [package insert]: Chadds Ford, Penn, Endo Pharmaceuticals, 2007
4. Bailey EV, Stone TW: The mechanism of action of amantadine in Parkinsonism: a review. Arch Int Pharmacodyn Ther 1975; 216:246-262
5. Stroe AE, Hall J, Amin F: Psychotic episode related to phenylpropanolamine and amantadine in a healthy female. Gen Hosp Psychiatry 1995; 17:457-458
6. Flaherty JA, Bellur SN: Mental side effects of amantadine therapy: its spectrum and characteristics in a normal population. J Clin Psychiatry 1981; 42:344-345
7. Yang CC, Deng JF: Anticholinergic syndrome with severe rhabdomyolysis: an unusual feature of amantadine toxicity. Intensive Care Med 1997; 23:355-356